重症患者阵发性事件的连续脑电图评估:诊断率及对临床决策的影响
本研究纳入2018年1月1日至2019年12月31日ICU中因阵发性事件接受cEEG监测(>6小时)的159份记录。29%(46/159)为阳性诊断率,包括发作期或发作间期癫痫样放电(n=33)和捕获习惯性非癫痫事件(n=13)。癫痫病史是研究结局的唯一预测因素,多数患者(30/46,65%)在记录6小时内检出异常。cEEG总体导致49例(31%)抗癫痫药物给药变化,包括癫痫样放电患者增加剂量或启动药物(n=28),以及习惯性非癫痫事件(n=5)或阴性cEEG(n=16)患者减少或停用药物。
要点
- ICU阵发性事件行cEEG(>6小时)的阳性诊断率为29%(46/159),其中癫痫样放电33例、习惯性非癫痫事件13例。
- 癫痫病史是cEEG阳性诊断结局的唯一预测因素。
- 多数阳性发现出现在记录6小时内(30/46,65%)。
- cEEG导致31%(49/159)的抗癫痫药物调整:癫痫样放电患者增加剂量或启动药物28例,习惯性非癫痫事件或阴性cEEG患者减少或停用药物分别为5例和16例。
- 异常运动是cEEG监测最常见的阵发性事件类型(123/159),其余36例包括凝视偏差、言语改变和感觉改变。
适用人群与场景
- ICU中因阵发性事件接受cEEG监测(>6小时)的危重患者,监测时间范围为2018年1月1日至2019年12月31日。
- 阵发性事件类型以异常运动为主(n=123),其余(n=36)包括凝视偏差、言语改变和感觉改变。
诊断标准与关键阈值
- 阳性诊断率(Y+)定义为cEEG捕获习惯性非癫痫事件或显示癫痫样放电(发作期或发作间期);阴性诊断率(Y-)为未显示上述发现。
研究设计与关键结果
- 研究类型为对159份cEEG记录的评估,患者来自ICU,因阵发性事件行cEEG监测(>6小时)。
- 29%(46/159)的记录为阳性诊断率(Y+),包括发作期或发作间期癫痫样放电(n=33)和捕获习惯性非癫痫事件(n=13)。
- 癫痫病史是研究结局的唯一预测因素。
- 多数患者(30/46,65%)在记录6小时内检出异常发现。
- cEEG总体导致49例(31%)抗癫痫药物给药变化:癫痫样放电患者增加剂量或启动药物(n=28),习惯性非癫痫事件患者减少或停用药物(n=5),阴性cEEG患者减少或停用药物(n=16)。
证据类型、等级与局限
- 证据类型:单中心评估cEEG诊断率与临床影响的观察性研究(原文未明确写出研究设计类型,仅描述为识别患者并提取资料)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对ICU中阵发性事件(尤其是异常运动)的患者,cEEG监测(>6小时)可提供29%的阳性诊断率,多数阳性发现在6小时内出现。
- 癫痫病史可预测cEEG阳性诊断结局,可据此选择优先监测人群。
- cEEG结果(包括阳性和阴性)可直接影响临床决策,导致31%的抗癫痫药物调整:阳性癫痫样放电者增加或启动药物,阴性或捕获习惯性非癫痫事件者减少或停用药物。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Continuous electroencephalogram (cEEG) monitoring has been widely used in the intensive care unit (ICU) for the evaluation of patients in the ICU with altered consciousness to detect nonconvulsive seizures. We investigated the yield of cEEG when used to evaluate paroxysmal events in patients in the ICU and assessed the predictors of a diagnostic findings. The clinical impact of cEEG was also evaluated in this study.
METHODS: We identified patients in the ICU who underwent cEEG monitoring (> 6 h) to evaluate paroxysmal events between January 1, 2018, and December 31, 2019. We extracted patient demographics, medical history, neurological examination, brain imaging results, and the description of the paroxysmal events that necessitated the monitoring. We dichotomized the cEEG studies into those that captured habitual nonepileptic events or revealed epileptiform discharges (ictal or interictal), i.e., those considered to be of positive diagnostic yield (Y +), and those studies that did not show those findings (negative diagnostic yield, Y -). We also assessed the clinical impact of cEEG by documenting changes in administered antiseizure medication (ASM) before and after the cEEG.
RESULTS: We identified 159 recordings that were obtained for the indication of paroxysmal events, of which abnormal movements constituted the majority (n = 123). For the remaining events (n = 36), descriptions included gaze deviations, speech changes, and sensory changes. Twenty-nine percent (46 of 159) of the recordings were Y + , including the presence of ictal or interictal epileptiform discharges (n = 33), and captured habitual nonepileptic events (n = 13). A history of epilepsy was the only predictor of the study outcome. Detection of abnormal findings occurred within 6 h of the recording in most patients (30 of 46, 65%). Overall, cEEG studies led to 49 (31%) changes in ASM administration. The changes included dosage increases or initiation of ASM in patients with epileptiform discharges (n = 28) and reduction or elimination of ASM in patients with either habitual nonepileptic events (n = 5) or Y - cEEG studies (n = 16).
CONCLUSIONS: Continuous electroencephalogram monitoring is valuable in evaluating paroxysmal events, with a diagnostic yield of 29% in critically ill patients. A history of epilepsy predicts diagnostic studies. Both Y + and Y - cEEG studies may directly impact clinical decisions by leading to ASMs changes.
参考来源
- Chen H, Atallah E, Pauldurai J, et al. Continuous Electroencephalogram Evaluation of Paroxysmal Events in Critically Ill Patients: Diagnostic Yield and Impact on Clinical Decision Making. Neurocrit Care. 2022. PMID: 35764859. doi:10.1007/s12028-022-01542-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。